FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/06/054516 [Registered on: 28/06/2023] Trial Registered Prospectively
Last Modified On: 27/06/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Biological 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   comparison of effectiveness of two interventions in improvement of pain and function in adhesive capsulitis 
Scientific Title of Study   Effectiveness of ultrasound guided intraarticular injection of platelet rich plasma compared with triamcinolone hexacetonide in improvement of pain and function in patients with adhesive capsulitis: A randomized controlled trial 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Yendrembam Anamika Chanu 
Designation  Post graduate student 
Affiliation  Regional Institute of Medical Sciences 
Address  Department of Physical Medicine and Rehabilitation, Regional Institute of Medical Sciences, Lamphelpat, Imphal

Imphal West
MANIPUR
795004
India 
Phone  9383280981  
Fax    
Email  yendrembamanamika@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Naorem Bimol 
Designation  Associate Professor 
Affiliation  Regional Institute of Medical Sciences 
Address  Department of Physical Medicine and Rehabilitation, Regional Institute of Medical Sciences, Lamphelpat, Imphal

Imphal West
MANIPUR
795004
India 
Phone  7005291542  
Fax    
Email  bimoldr@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Naorem Bimol 
Designation  Associate Professor 
Affiliation  Regional Institute of Medical Sciences 
Address  Department of Physical Medicine and Rehabilitation, Regional Institute of Medical Sciences, Lamphelpat, Imphal

Imphal West
MANIPUR
795004
India 
Phone  7005291542  
Fax    
Email  bimoldr@yahoo.com  
 
Source of Monetary or Material Support  
Regional Institute of Medical Sciences,Lamphelpat, Imphal- 795004, Manipur, India 
 
Primary Sponsor  
Name  Yendrembam Anamika Chanu 
Address  Post graduate trainee, Department of Physical Medicine and Rehabilitation, Regional Institute of Medical Sciences,Lamphelpat, Imphal- 795004, Manipur, India 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
Nil  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Yendrembam Anamika Chanu  Regional Institute of Medical Sciences  Department of Physical Medicine and Rehabilitation Regional Institute of Medical Sciences Lamphelpat, Imphal- 795004
Imphal West
MANIPUR 
9383280981

yendrembamanamika@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Research Ethics Board, Regional Institute of Medical Sciences  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M750||Adhesive capsulitis of shoulder,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Intra-articular injection of Platelet rich plasma into the shoulder  Single injection of 4ml Platelet rich plasma into the shoulder joint under ultrasound guidance 
Comparator Agent  Intra-articular injection of Triamcinolone hexacetonide into the shoulder joint  Single Injection of 1ml Triamcinolone hexacetonide 20mg/ml into the shoulder joint under ultrasound guidance 
 
Inclusion Criteria  
Age From  40.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Diagnosed case of adhesive capsulitis,
Patients who are willing to comply with the study and follow up assessments
 
 
ExclusionCriteria 
Details  Patients with uncontrolled diabetes
History of shoulder trauma/surgery
History of injection in the shoulder joint in past three months
Non-steroidal anti-inflammatory drugs intake in last seven days
Coagulopathy
Thrombocytopenia (1.5 lakh/microlitre)
Autoimmune disorders
Impaired cognition
Any febrile or infectious disease (systemic & local)
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Shoulder Pain and Function in terms of Shoulder Pain and Disability Index (SPADI)  1 week, 4 week, 12 week, 24 week 
 
Secondary Outcome  
Outcome  TimePoints 
Pain in terms of Visual Analogue Scale (VAS)  1 week, 4 weeks, 12 weeks, 24 weeks 
Shoulder function in terms of Range of Motion  1 week, 4 weeks, 12 weeks, 24 weeks 
 
Target Sample Size   Total Sample Size="64"
Sample Size from India="64" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   05/07/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="4"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
This study is a randomized, parallel group, active control trial comparing the effectiveness of ultrasound guided intra articular injection of 4ml Platelet rich plasma with 1 ml triamcinolone hexacetonide 20mg/ml in improvement of pain and function in 64 patients with adhesive capsulitis of shoulder. This study will be conducted in Department of Physical Medicine and Rehabilitation , Regional Institute of Medical Sciences, Imphal, Manipur in India. The primary outcome measures will be improvement in pain and function as measured by SPADI  and secondary outcome measures will be pain measured by VAS and shoulder function measured by Range of motion which all will be asses at 1week, 4weeks, 12 weeks and 24 weeks post intervention.
 
Close